← Leaderboards
Peggy Lalor
Vical, Inc.
$3,895,660
Attributed
$3,895,660
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,895,660 · 1
By mechanism
R44$3,895,660 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Trial Phase I”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Clinical Trial Phase IDrug Screening /EvaluationLaboratory MouseBioterrorism /Chemical WarfareBacillus AnthracisBacterial ToxinsClinical ResearchGene Delivery SystemHuman SubjectHuman Therapy EvaluationLaboratory RabbitLethal GenesMacaca FascicularisNonhuman Therapy EvaluationPatient Oriented ResearchPlasmidsSporesVaccine DevelopmentActive ImmunizationVector VaccineAnthraxAnthrax ToxinAnthrax Vaccines